Phibro Animal Health Corp
PAHC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069899
No open-market purchases or sales by Phibro Animal Health Corp insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $660.4M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −46 vs. previous quarter
- 208
- 13F valueReported value at the end of Q2 2026
- $660.4M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PAHC, Q2 2026
No superinvestor reported holding PAHC at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Phibro Animal Health Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 (view filing) | May 29 | 4 days | Corcoran E ThomasDirector | PPurchaseClass A Common Stock | +10.0K | $31.77 | +$317.7K | +31.8%41.5K after | |
| May 7, 2026 (view filing)7:34 PM ET | May 5-7 | 2 days | Bendheim Jack and 1 otherPresident and CEO | SSaleClass A Common Stock | −18.6K | $54.61 | −$1.02M | −24.9%56.2K after | 7 lots10b5-1 |
| Apr 30, 2026 (view filing)7:20 PM ET | Apr 28-30 | 2 days | Bendheim Jack and 1 otherPresident and CEO | SSaleClass A Common Stock | −21.1K | $53.86 | −$1.14M | −22.0%74.8K after | 7 lots10b5-1 |
| Apr 23, 2026 (view filing)7:30 PM ET | Apr 21-23 | 2 days | Bendheim Jack and 1 otherPresident and CEO | SSaleClass A Common Stock | −21.1K | $54.79 | −$1.16M | −18.1%95.9K after | 5 lots10b5-1 |
| Apr 16, 2026 (view filing)8:25 PM ET | Apr 14-16 | 2 days | Bendheim Jack and 1 otherPresident and CEO | SSaleClass A Common Stock | −21.1K | $56.89 | −$1.20M | −15.3%117.0K after | 7 lots10b5-1 |
| Mar 31, 2026 (view filing)6:44 PM ET | Mar 30-31 | 1 day | Bendheim Jack and 1 otherPresident and CEO | SSaleClass A Common Stock | −14.1K | $53.75 | −$756.8K | −27.0%38.1K after | 4 lots10b5-1 |
| Mar 26, 2026 (view filing)9:19 PM ET | Mar 24-26 | 2 days | Bendheim Jack and 1 otherPresident and CEO | SSaleClass A Common Stock | −21.1K | $55.21 | −$1.17M | −28.8%52.2K after | 7 lots10b5-1 |
| Mar 19, 2026 (view filing)7:58 PM ET | Mar 17-19 | 2 days | Bendheim Jack and 1 otherPresident and CEO | SSaleClass A Common Stock | −22.9K | $52.40 | −$1.20M | −23.8%73.3K after | 7 lots10b5-1 |
| Mar 16, 2026 (view filing)4:15 PM ET | Mar 13 | 3 days | Bendheim Jack and 1 otherPresident and CEO | SSaleClass A Common Stock | −5.28K | $48.91 | −$258.2K | −5.2%96.2K after | 10b5-1 |
| Feb 26, 2026 (view filing)7:09 PM ET | Feb 24-26 | 2 days | Bendheim Jack and 1 otherPresident and CEO | SSaleClass A Common Stock | −21.1K | $52.27 | −$1.10M | −93.5%1.48K after | 5 lots10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Phibro Animal Health Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3,219,040 | $101.1M | 0.00% | −34,808−1.1% | Reduced |
| FMR LLC | 3,160,281 | $99.2M | 0.00% | +987,155+45.4% | Added |
| State Street Corp | 1,038,382 | $32.6M | 0.00% | +88,349+9.3% | Added |
| Millennium Management LLC | 936,701 | $29.4M | 0.02% | +880,882+1,578.1% | Added |
| Vanguard Capital Management LLC | 923,318 | $29.0M | 0.00% | +32,035+3.6% | Added |
| Geode Capital Management, LLC | 657,350 | $20.6M | 0.00% | +52,702+8.7% | Added |
| Lord, Abbett & Co. LLC | 653,305 | $20.5M | 0.06% | +255,591+64.3% | Added |
| Dimensional Fund Advisors LP | 531,087 | $16.7M | 0.00% | +23,235+4.6% | Added |
| Vanguard Portfolio Management LLC | 508,486 | $16.0M | 0.00% | +18,144+3.7% | Added |
| Renaissance Technologies LLC | 480,500 | $15.1M | 0.02% | −96,235−16.7% | Reduced |